Exhibit 4.3
DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
The following description summarizes certain important terms of the securities of GreenLight Biosciences Holdings, PBC, formerly Environmental Impact Acquisition Corp. (“we,” “us,” “our,” the “Company” or “New GreenLight”) as of March 15, 2022. Because the following description is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth in this document, you should refer to our Second Amended and Restated Certificate of Incorporation (the “Charter”) , our Amended and Restated Bylaws (the “Bylaws”), the Warrant Agreement, dated January 13, 2021, between us and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), the Investor Rights Agreement, dated August 9, 2021, between us and the signatories identified on Schedule A attached thereto (the “Investor Rights Agreement”), and the Business Combination Agreement, dated August 9, 2021 (the “Business Combination Agreement”, and the transactions contemplated thereby, the “Business Combination”), by and among us and GreenLight Biosciences, Inc. (“GreenLight”), which are included as exhibits to New GreenLight’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “Annual Report”), of which this Exhibit forms a part, and to the applicable provisions of the Delaware General Corporation Law (the “DGCL”).
As of the March 15, 2022, we have two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.0001 per share (the “New GreenLight Common Stock”), and public warrants to purchase New GreenLight Common Stock (the “Public Warrants”).
Authorized Capitalization
New GreenLight’s authorized capital stock consists of 500,000,000 shares of New GreenLight Common Stock, and 10,000,000 shares of preferred stock, par value $0.0001 per share (the “New GreenLight Preferred Stock”). No shares of New GreenLight Preferred Stock are issued or outstanding as of March 15, 2022. Unless the New GreenLight Board determines otherwise, New GreenLight will issue all shares of its capital stock in uncertificated form.
Common Stock
Holders of shares of New GreenLight Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. The holders of shares of New GreenLight Common Stock do not have cumulative voting rights in the election of directors.
Upon New GreenLight’s liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to any future holders of New GreenLight Preferred Stock having liquidation preferences, if any, the holders of shares of New GreenLight Common Stock will be entitled to receive, pro rata, New GreenLight’s remaining assets available for distribution. Holders of shares of New GreenLight Common Stock do not have preemptive, subscription, redemption or conversion rights. There will be no sinking fund provisions